Comprehensive Analysis of Hypermutation in Human Cancer
Brittany Campbell(Hospital for Sick Children), Melyssa Aronson, Scott Lindhorst, Katharina Wimmer(Innsbruck Medical University), David Fabrizio(Foundation Medicine (United States)), Zucai Suo(The Ohio State University), Kristina A. Cole(Children's Hospital of Philadelphia), Matthew Zatzman(University of Toronto), Fabio Fuligni(Hospital for Sick Children), Scott Davidson(Hospital for Sick Children), Gary Mason, Roula Farah, David Samuel(Children's Hospital Central California), Tatiana Lipman(Hospital for Sick Children), Magnus Sabel(University of Gothenburg), Jiil Chung(Hospital for Sick Children), Melissa A. Galati(Hospital for Sick Children), Meredith S. Irwin(University of Toronto), Vijay Ramaswamy(Hospital for Sick Children), Ronit Elhasid, David S. Ziegler(Cancer Institute of New South Wales), Rina Dvir, Phillip B. Storm(Children's Hospital of Philadelphia), Annie Huang(Hospital for Sick Children), Walter J. Zahurancik(The Ohio State University), Karl P. Hodel(Tulane University), Vanan Magimairajan Issai(CancerCare Manitoba), Nicholas Light(University of Toronto), Julia A. Elvin(Foundation Medicine (United States)), Peter B. Dirks(Hospital for Sick Children), Pichai Raman(Children's Hospital of Philadelphia), Richard de Borja, Annika Bronsema(Universität Hamburg), Daniel C. Bowers(Southwestern Medical Center), Shlomi Constantini(Tel Aviv University), Christian P. Kratz(Medizinische Hochschule Hannover), Gavin P. Dunn(Brigham Young University), Tanner M. Johanns(Washington University in St. Louis), Matthew Grimmer(Sequenom (United States)), Valérie Larouche, Ben George(Medical College of Wisconsin), Helen Toledano(Tel Aviv University), Duncan Stearns(Rainbow Babies & Children's Hospital), Theodore W. Laetsch(Children's Hospital of Philadelphia), Enrico Opocher(University of Padua), Gregory A. Thomas(Oregon Health & Science University), Ivan Smirnov(University of California, San Francisco), Michael Osborn, Michal Yalon(Sheba Medical Center), Melissa Edwards(Hospital for Sick Children)
Cited by 795
Related Papers
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
|Nature|2012|8.5k
Blood-based tumor mutational burden as a predictor of clinical benefit in non-small-cell lung cancer patients treated with atezolizumab
|Nature Medicine|2018|1.2k
Glioma Stem Cell Lines Expanded in Adherent Culture Have Tumor-Specific Phenotypes and Are Suitable for Chemical and Genetic Screens
|Cell stem cell|2009|1.1k
Immune Checkpoint Inhibition for Hypermutant Glioblastoma Multiforme Resulting From Germline Biallelic Mismatch Repair Deficiency
|Journal of Clinical Oncology|2016|867
Revised diagnostic criteria for neurofibromatosis type 1 and Legius syndrome: an international consensus recommendation
|Genetics in Medicine|2021|766